Optiver Holding
CTNM

Optiver Holding’s Contineum Therapeutics CTNM Stock Holding History

Optiver Holding’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393 Buy
+24
New +$315 ﹤0.01% 2589
2026
Q1 		– Sell
-104
Closed -$1.19K – 2793
2025
Q4 		$1.19K Hold
104
– – ﹤0.01% 2185
2025
Q3 		$1.22K Buy
+104
New +$838 ﹤0.01% 2478

Other funds holding CTNM

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Optiver Holding's CTNM Position: Q2 2026 in Review

Optiver Holding opened a new position in Contineum Therapeutics (CTNM) in Q2 2026: 24 shares worth $393. The stake represents ﹤0.01% of the portfolio and ranks #2589 among its holdings. This is a return to the name: Optiver Holding previously reported a position in CTNM as recently as Q4 2025.

Optiver Holding first reported a position in CTNM in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.22K in Q3 2025. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • Optiver Holding held 24 shares of Contineum Therapeutics worth $393 as of Q2 2026.
  • Contineum Therapeutics was a new Optiver Holding position in Q2 2026.
  • Contineum Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2589 holding.
  • Optiver Holding first reported a position in Contineum Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Contineum Therapeutics position peaked at $1.22K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.